Holds 2 active US DMFs for eletriptan, filing since 2012. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 6 markets.
Holds one active US DMF for eletriptan, filing since 2017. Its 2025 FDA inspection closed as VAI.
Holds one active US DMF for eletriptan, filing since 2010. Its 2022 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds 2 active US DMFs for eletriptan, filing since 2010. Its 2025 FDA inspection closed as VAI.
Holds one active US DMF for eletriptan, filing since 2016. Its 2024 FDA inspection closed as VAI.
Holds one active US DMF for eletriptan, filing since 2015. Its GMP is recognised in 1 market.
Holds 2 active US DMFs for eletriptan, filing since 2011. Its 2025 FDA inspection closed as OAI, and its GMP is recognised in 6 markets.
Registered with SFDA (Saudi Arabia) for eletriptan. Its 2025 FDA inspection closed as OAI, and its GMP is recognised in 21 markets.
Registered with SFDA (Saudi Arabia) for eletriptan. Its GMP is recognised in 1 market.
The names are listed below. Ask Fred about the filings, inspection history and GMP certificates on record for each manufacturer.
Contract manufacturers make to order rather than holding their own filing for this molecule.
The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Ask Fred which manufacturers are on record for eletriptan and what filings they hold.
Chat with Fred, your AI analyst| Year | Median | Exporters |
|---|---|---|
| 2024 | $3677.05 | 7 |
| 2023 | $5434.78 | 7 |
| 2022 | $4528.56 | 7 |
US dollars per kilogram, customs export unit values.